EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
ExpreS2ion Biotechnologies
Vice President - Business Development
ExpreSion Biotechnologies protein expression system ExpreS is an important protein expression tool in the scientists tool box for protein expression The ExpreS platform has demonstrated in many instances its usefulness in RD with several ExpreSmade proteins having now been crystallized
Articles
The Emergence of Organ-on-chips for Diseases Studies and Drug Development
In recent years Organonchips OOC attracted large interest as a new enabling technology to better understand human pathophysiological mechanisms and develop new drug treatments
Research Insights
COVID-19 Infection and Transmission Includes Complex Sequence Diversity
SARSCoV whole genome sequencing has played an important role in documenting the emergence of polymorphisms in the viral genome and its continuing evolution during the COVID pandemic Here we present data from over patients to characterize the complex sequence diversity of individual
Case Studies
Solid Form Changes During Drug Development: Good, Bad, And Ugly Case Studies
The relevance of solid form in drug development has been well established over time In order to fully understand drug properties attention has been paid to solid state structure of drug molecules and their relationship to the drug formulation While each drug developer has had their own strategies and workflows for screening and choosing solid forms of drug molecules t...
Techno Trends
Australian Scientists Discover Breakthrough in Lung Cancer Treatment
Australian scientists have discovered a breakthrough in lung cancer treatment They discovered the origin cell of a common form of lung cancer that kills thousands of smokers and nonsmokers This would help to detect squamous cell lung cancer that accounts for up to per cent of all lung cancers Scientists will take years to complete the breakthrough They observed...
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Industry 4.0 at Bachem
Elodie Decuypere received her Ph.D in Organic Synthesis from the University of Paris-Saclay with specialization in Click Chemistry. After her Ph.D, Elodie specialized in oligonucleotide chemistry with her two postdoc in ETH Zürich and Roche Basel. In 2020, Elodie joined Bachem as a Specialist Marketing and works on the creation of scientific content for marketing materials.
Six Sigma - Time, cost and product quality improvement
Ashwin Kuchekar is an Associate Professor and the Head of Career Services and Placement at the School of Pharmacy, Dr. Vishwanath Karad MIT-WPU in Pune. He completed his M. Pharm.in 2009 and Ph. D. in 2015. In 2012, he received the Senior Research Fellow (SRF) Award from the Council of Scientific Industrial and Research (CSIR). He is a trained specialist in Lean Six Sigma Black Belt (LSSBB). He has 7 years of industrial experience in reputed pharmaceutical companies such as Piramal, Lupin, and Abbott Healthcare. He has a unique blend of statistics and formulation development, Quality by Design with exposure to branded and generic product development. He has practical experience in the Design of Experiments and product formulation and process optimisation.
Determinants of Antimicrobial Resistance (AMR) Research in South East Asia
Raja Chakraverty is a serving Scientist with the Indian Council of Medical Research with a decade long research and teaching career in Pharmaceutical Sciences with 54 publications (186 citations) and a book
Doctoral Scholar, Department of Pharmaceutical Technology
The Growing Role of Biocatalysis in Industrial Synthesis
Dr Reuben Carr has over 25 years of experience in developing proprietary biocatalytic processes for fine chemical and pharmaceutical manufacturing. He specialises in using directed evolution to engineer natural enzymes to carry out novel chemical reactions, enabling the synthesis of challenging molecular targets for clients and customers.
The Role of Technology in Continued Process Verification 4.0
Dr. Kavita is a seasoned leader in the field of data and insights, with over 20 years of invaluable experience. She is a result-oriented solution designer in data warehouse and big data analytics. Drawing from her extensive in multinational organisations IBM, Capgemini, and others, Kavita has successfully overseen numerous large and intricate projects. Her expertise lies in effectively leveraging her robust technical knowledge in areas such as data warehousing and business intelligence to drive impactful outcomes. Under Dr. Kavita's exceptional leadership, the CaliberAPQR product has achieved outstanding recognition.
press releasesRead more...
CAS Connections brings trusted scientific data and AI to leading R&D platforms
CAS a division of the American Chemical Society specializing in scientific knowledge management today announced CAS Connections a new integration framework that embeds the CAS Content Collection
Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®
Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA today announced the launch of AHZANTIVE aflibercept a biosimilar to Eylea in Europe further strengthening the Companys growing biosimilars portfolio and expanding
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Amneal Pharmaceuticals Inc Amneal or the Company Nasdaq AMRX today announced that the US Food and Drug Administration FDA has approved the Companys romidepsin injection solution mg mL
DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration
DaltonTx the intelligence backbone for modern drug discovery connecting AI human expertise and experimental data today announced the launch of Dalton its drug discovery platform
Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
Iovance Biotherapeutics Inc NASDAQ IOVA a commercial biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte TIL therapies for patients with cancer
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer
Arcus Biosciences Inc NYSE RCUS a clinicalstage global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases
EventsRead more...
04 - 05
Jun 2026Pharmac South 2026
Chennai Trade Centre, Nandamba...
04 - 05
Jun 2026Global Bioprocessing Summit & Exhibition 2026
Berlin, Germany
09 - 11
Jun 20265th World ADC Summit South Korea
COEX Magok Lewest, 143 Magokju...
09 - 11
Jun 2026World TPD & Induced Proximity Summit South Korea
COEX Magok Lewest, 143 Magokju...
09 - 11
Jun 2026World Targeted Therapeutics Summit South Korea
COEX Magok Lewest, 143 Magokju...
09 - 10
Jun 2026ChemE Show 2026
George R. Brown Convention Cen...
10 - 11
Jun 2026Novel Ingredients for Infant Nutrition Summit
The Westin Washington Dulles A...
10 - 11
Jun 202617th Annual Clinical Trials Summit 2026
Mumbai, India
LATEST NEWSRead more...
Stipple Bio Signs Licensing Agreement with Lonza for Precision Oncology ADC Development
Stipple Bio has entered a multitarget licensing agreement with Lonza to support the development of nextgeneration antibodydrug conjugate ADC therapies for cancer treatment
Biogen’s Salanersen Granted FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Biogen announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen for the treatment of spinal muscular atrophy SMA
Chai Discovery Signs Licensing Agreement with Pfizer to Advance AI-Driven Drug Discovery
Chai Discovery has entered into a licensing agreement with Pfizer to support the use of artificial intelligence in drug discovery and accelerate the development of new medicines
Alnylam and Inceptive Partner to Accelerate RNAi Drug Discovery Using AI
Alnylam Pharmaceuticals Inc and Inceptive Nucleics Inc have entered into a strategic collaboration aimed at accelerating the discovery and development of RNA interference RNAi therapeutics through the use of artificial intelligence
Massive Bio and Optellum Partner to Improve Clinical Trial Access for Early-Stage Lung Cancer Patients
Massive Bio and Optellum have entered into a collaboration aimed at improving access to clinical trials for patients with earlystage nonsmall cell lung cancer NSCLC The partnership combines Optellums artificial intelligence
Travere Therapeutics Signs Licensing Agreement with Everest Medicines for Civorebrutinib
Travere Therapeutics has entered into an exclusive licensing and collaboration agreement with Everest Medicines for the development and commercialisation of civorebrutinib EVER an investigational oral Brutons tyrosine kinase